This inventor holds 1 USPTO granted patent. Top assignee: American Cyanamid Company. Active years: 1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998
Title: Innovations of Yuri E Raifeld
Introduction
Yuri E Raifeld is a notable inventor based in Tarrytown, NY (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of antiviral agents. His work has led to the creation of innovative compounds that have the potential to treat viral infections effectively.
Latest Patents
Yuri E Raifeld holds a patent for "Triazine containing anionic compounds useful as antiviral agents." This invention provides triazine ring containing anionic compounds, pharmaceutical compositions containing these compounds, and methods utilizing these compounds for treating viral infections, particularly infections by respiratory syncytial virus. The compounds have a general structure that includes pharmaceutically acceptable salts.
Career Highlights
Raifeld has worked with American Cyanamid Company, where he has been able to apply his expertise in developing pharmaceutical solutions. His innovative approach has contributed to advancements in antiviral therapies, showcasing his commitment to improving public health.
Collaborations
Throughout his career, Yuri E Raifeld has collaborated with notable colleagues, including Yakov Gluzman, who is now deceased, and James P LaRocque. These collaborations have enriched his research and development efforts, leading to impactful innovations.
Conclusion
Yuri E Raifeld's contributions to the field of antiviral agents highlight his role as a significant inventor. His work continues to influence the pharmaceutical industry and offers hope for effective treatments against viral infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile